Brain tumours are regarded as one of the less common
cancers, representing just 1.8% of all cancers, yet they often feature at the
worse end of statistical measures such as mortality, years of life lost (YLL)
and caregiver burden. Whilst not all brain tumours are cancerous, benign tumours
can result in similar symptoms. The road to better outcomes for brain tumour
patients is signposted by more funding, more research, and ultimately more
effective treatments, but it starts with increased awareness and education. The
International Brain Tumour Awareness Week (22-29 October 2016) provides an opportunity for people
from around the world to organise or participate in an awareness raising
activity for brain tumours.
Many different types of brain tumours and brain cancers exist, which means that the cause for each is very different and sometimes is not known. This is why we need to invest in research. For the vast
majority of people with a brain tumour, no outside cause can be clearly
identified. Most astrocytomas and oligodendrogliomas occur when there is damage (a
mutation) in genes that control how a cell grows and multiplies. The cells with
the gene mutation develop into the tumour, but the abnormality cannot be
inherited by the person’s children.
The symptoms of a brain tumour vary widely and depend on what
part of the brain the tumour is pressing on. Symptoms may be associated with
the type, size, and/or location of the tumour. Symptoms may also be caused by the treatments used to manage it. Surgery, radiation,
chemotherapy, and other treatments all have the potential to
generate new symptoms as they work to reduce the impact of the tumour.
More information about brain tumour symptoms and diagnosis
can be found here from
the Brain Foundation in Australia or here from.
To find out more about Brain Tumour Awareness Week click here.
If you have further questions, we recommend speaking to a healthcare professional.
Sourced from
Cure Brain Cancer
25 Oct 2016
Health Facts
Subscribe to our mailing list to recieve regular e-mails from the Whitecoat team.
by Whitecoat